Roger D. Dansey - 21 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Roger Dansey
Issuer symbol
INO
Transactions as of
21 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 16:57:32 UTC
Previous filing
26 Jun 2024
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DANSEY ROGER D Director 660 W. GERMANTOWN PIKE SUITE 110, PLYMOUTH MEETING /s/ Roger Dansey 21 May 2025 0001741836

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +2,167 +32% 8,916 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -2,167 -100% $0.000000 0 21 May 2025 Common Stock 2,167 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025.